The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 03, 2020
Filed:
Dec. 09, 2016
Applicants:
Corvus Pharmaceuticals, Inc., Burlingame, CA (US);
Bioatla, Llc, San Diego, CA (US);
Inventors:
Emily Piccione Griffin, Belmont, CA (US);
Richard A. Miller, Portola Valley, CA (US);
Gerhard Johann Frey, San Diego, CA (US);
Hwai Wen Chang, San Marcos, CA (US);
Assignees:
CORVUS PHARMACEUTICALS, INC., Burlingame, CA (US);
BIOATLA, LLC, San Diego, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); G01N 33/573 (2006.01); G01N 33/84 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); A61P 35/00 (2018.01); G01N 33/573 (2013.01); G01N 33/84 (2013.01); C07K 2317/24 (2013.01); C07K 2317/52 (2013.01); C07K 2317/565 (2013.01); C07K 2317/71 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2333/916 (2013.01);
Abstract
Provided herein are, inter alia, humanized 1E9 antibodies capable of binding CD73. The humanized antibodies are useful for the treatment of cancer. Further provided are nucleic acids encoding humanized 1E9 antibodies and methods of inhibiting cell proliferation using the humanized antibodies provided herein.